ClinicalTrials.Veeva

Menu

The Effect of Dexmedetomidine to Cognition of Geriatrics in Prolonged Surgery

S

Shaanxi Provincial People's Hospital

Status and phase

Unknown
Phase 4

Conditions

Brain Injury
Cognitive Ability, General

Treatments

Drug: Induction of anesthesia
Drug: Placebo
Drug: Dexmedetomidine
Procedure: Intubation
Drug: Sevoflurane, remifentanil ,vecuronium

Study type

Interventional

Funder types

Other
NETWORK

Identifiers

NCT02123355
SPPHA01

Details and patient eligibility

About

The incidence of postoperative cognitive dysfunction (POCD) is high and POCD affect the life quality and the prognosis of patients. Geriatrics is the independent risk factor of POCD, and POCD is also correlated with many other factors such as type of surgery, the duration of anesthesia and the anesthesia drugs used et al. So, the prevention and treatment of POCD in geriatrics is important.

Dexmedetomidine is found to have the effect of neuro-protection, but it is controversy whether Dexmedetomidine has the effect of neuro-protection in geriatrics, especially the prolonged surgery.

The purpose of this study is to explore the effect of Dexmedetomidine to the cognitive function at prolonged surgery in geriatrics in geriatrics.

Enrollment

80 estimated patients

Sex

All

Ages

65+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Written informed consent
  2. Scheduled for elective abdominal surgery
  3. Age≥65 yrs
  4. Weight is within the range of ±20% of standard weight [standard weight=Height(cm)-80)×70﹪ for male and(Height(cm)-70)×60﹪] for female
  5. American society of anesthesia classification I~III
  6. Expected time of surgery is more than 4 hours -

Exclusion criteria

  1. Systolic blood pressure≥180 mm Hg or <90 mm Hg,diastolic blood pressure≥110 mm Hg or < 60 mm Hg;
  2. Serious cardiac,liver,kidney,lung, endocrine disease or sepsis.
  3. Allergy to trial drug or other contraindication;
  4. Difficult airway occurred before,or difficult airway possibly occurred and difficult to extubation
  5. History of mental illness and cerebral vascular disease
  6. History of unstable angina or myocardial infarction
  7. Education level<7 yrs
  8. Factors existed that affect cognition assessment such as language, visual sense,auditory sense disorders.
  9. Abuse of narcotic analgesia or suspected;
  10. Neuromuscular diseases;
  11. Mentally unstable or has a mental illness;
  12. Pregnant or breast-feeding women;
  13. Attended other trial past 30 days; -

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

80 participants in 2 patient groups

Dexmedetomidine
Experimental group
Description:
Dexmedetomidine is given at 0.5μg/kg/h by continuous infusion and is stopped to given 30 minutes before the surgery is over.
Treatment:
Drug: Induction of anesthesia
Procedure: Intubation
Drug: Dexmedetomidine
Drug: Sevoflurane, remifentanil ,vecuronium
Normal saline
Sham Comparator group
Description:
Normal saline is given at 0.5μg/kg/h by continuous infusion and is stopped to given 30 minutes before the surgery is over.
Treatment:
Drug: Induction of anesthesia
Procedure: Intubation
Drug: Sevoflurane, remifentanil ,vecuronium
Drug: Placebo

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems